Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A tumor growth inhibition model for low-grade glioma treated with chemotherapy or radiotherapy.
Ribba B, Kaloshi G, Peyre M, Ricard D, Calvez V, Tod M, Cajavec-Bernard B, Idbaih A, Psimaras D, Dainese L, Pallud J, Cartalat-Carel S, Delattre JY, Honnorat J, Grenier E, Ducray F. Ribba B, et al. Among authors: cartalat carel s. Clin Cancer Res. 2012 Sep 15;18(18):5071-80. doi: 10.1158/1078-0432.CCR-12-0084. Epub 2012 Jul 3. Clin Cancer Res. 2012. PMID: 22761472
Peri-ictal pseudoprogression in patients with brain tumor.
Rheims S, Ricard D, van den Bent M, Taillandier L, Bourg V, Désestret V, Cartalat-Carel S, Hermier M, Monjour A, Delattre JY, Sanson M, Honnorat J, Ducray F. Rheims S, et al. Neuro Oncol. 2011 Jul;13(7):775-82. doi: 10.1093/neuonc/nor082. Neuro Oncol. 2011. PMID: 21727213 Free PMC article.
Up-front temozolomide in elderly patients with glioblastoma.
Laigle-Donadey F, Figarella-Branger D, Chinot O, Taillandier L, Cartalat-Carel S, Honnorat J, Kaloshi G, Delattre JY, Sanson M. Laigle-Donadey F, et al. J Neurooncol. 2010 Aug;99(1):89-94. doi: 10.1007/s11060-009-0110-3. Epub 2010 Jan 8. J Neurooncol. 2010. PMID: 20058048
TEMOBIC: Phase II Trial of Neoadjuvant Chemotherapy for Unresectable Anaplastic Gliomas: An ANOCEF Study.
Tabouret E, Fabbro M, Autran D, Hoang-Xuan K, Taillandier L, Ducray F, Barrie M, Sanson M, Kerr C, Cartalat-Carel S, Loundou A, Guillevin R, Mokhtari K, Figarella-Branger D, Delattre JY, Chinot O. Tabouret E, et al. Among authors: cartalat carel s. Oncologist. 2021 Aug;26(8):647-e1304. doi: 10.1002/onco.13765. Epub 2021 Apr 20. Oncologist. 2021. PMID: 33783067 Free PMC article. Clinical Trial.
Advances in paraneoplastic neurological syndromes.
Honnorat J, Cartalat-Carel S. Honnorat J, et al. Curr Opin Oncol. 2004 Nov;16(6):614-20. doi: 10.1097/01.cco.0000142486.89472.eb. Curr Opin Oncol. 2004. PMID: 15627026 Review.
Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial.
Gállego Pérez-Larraya J, Ducray F, Chinot O, Catry-Thomas I, Taillandier L, Guillamo JS, Campello C, Monjour A, Cartalat-Carel S, Barrie M, Huchet A, Beauchesne P, Matta M, Mokhtari K, Tanguy ML, Honnorat J, Delattre JY. Gállego Pérez-Larraya J, et al. J Clin Oncol. 2011 Aug 1;29(22):3050-5. doi: 10.1200/JCO.2011.34.8086. Epub 2011 Jun 27. J Clin Oncol. 2011. PMID: 21709196 Clinical Trial.
[Neurological complications of cancer].
Cartalat-Carel S, Honnorat J. Cartalat-Carel S, et al. Rev Prat. 2003 Dec 15;53(19):2147-52. Rev Prat. 2003. PMID: 15008471 Review. French.
37 results